Fig 1.
Consolidated standards of reporting trials diagram for flow of study participants.
Table 1.
Basic characteristics of study patients by dexamethasone dose group.
Table 2.
Clinical improvement using the WHO-Ordinal scale for clinical improvement (WHO-OSCI).
Fig 2.
Kaplan-Meier survival curves a. in high-dose and low-dose groups and b. for subgroups with OSCI = 5 at randomization.
Table 3.
Day 14 and day 28 death in WHO-Ordinal scale for clinical improvement (WHO-OSCI) subgroups.
Table 4.
Outcomes for participants who required ICU care within 28 days (n = 38).